CONFERENCE
The COST action EPITRAN aims at fostering the development of the emerging field of epitranscriptomics in Europe. The aim is to understand the role of RNA modifications in physiology and pathology, and thus identify novel and powerful disease biomarkers and drug targets. Cancer treatment will be of particular interest of the network.
More information on the patners, length of the activity, etc. here: www.cost.eu/COST_Actions/ca/CA16120
 kick off meeting in Brussels was held. IMB UL researcher Dr. biol Janis Liepins, together with PhD. Med. Irina Kholodnyuk Holodnuka, researcher from A. Kirchenstein Institute of Microbiology and Virology are Latvia representatives of the network.){kind=link}